SGC in the News

Explore our news articles and stay connected with the SGC.

Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?


Cheryl Arrowsmith of SGC-Toronto elected a Fellow of the Royal Society of Canada

On September 8th, 2020, the Royal Society of Canada (RSC) elected Dr. Cheryl Arrowsmith, SGC-Toronto's Chief Scientist, as an RSC Fellow, the highest honour an individual can achieve in the Arts, Social Sciences and Sciences.

Cheryl Arrowsmith is a biomedical scientist internationally…

Open science drug discovery partnership, READDI, aims to invest $125 million to prevent future pandemics

(Chapel Hill, N.C.— April 7, 2020) — Today, the Structural Genomics Consortium (SGC), the University of North Carolina at Chapel Hill and the Eshelman Institute for Innovation, announce the launch of the Rapidly Emerging Antiviral Drug Development Initiative (READDI), a global…

National Institute on Aging awards $73 million for new Alzheimer’s drug discovery centers

 SGC and collaborating institutions will lead development of openly distributed tools to test the efficacy of Alzheimer’s therapies and rapidly share results

The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a grant…